Acino, a Swiss pharmaceutical company headquartered in Zurich, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Under the brand ‘Acino Switzerland’, Acino sells high-quality medicines in emerging markets with a strategic focus on the Middle East, Africa, Ukraine/CIS including Russia, and Latin America.
Location: Switzerland, Zurich
Employees: 1001-5000
Phone: +41 44 555 22 00
Founded date: 1836
Investors 2
| Date | Name | Website |
| - | Nordic Cap... | nordiccapi... |
| - | Avista Cap... | avistacap.... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 22.10.2021 | Acino acquires selected Aspen brands in South Africa | Zurich, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ZURICH, Switzerland, 22 October 2021 - Acino and Aspen Pha... | marketscre... |
| 22.10.2021 | Acino acquires selected Aspen brands in South Africa | Zurich, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ZURICH, Switzerland, 22 October 2021 - Acino and Aspen Pha... | globenewsw... |
| 20.09.2021 | Evergrande is in trouble. But it probably won’t be a Lehman ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 16.09.2021 | Nordic Capital and Avista Capital Partners to sell Acino, a ... | Nordic Capital and Avista Capital Partners to sell Acino, a leader in advanced drug delivery technol... | news.cisio... |
| - | Avista Capital Partners and Nordic Capital to sell Acino, a ... | — Ownership period defined by Acino’s transformation and growth to become leading provider of truste... | avistacap.... |